| Surgery | Lifetime | 305 | SE 8 | 99.74 |
| Rheumatology | Lifetime | 128 | SE 4 | 99.47 |
| Clinical Pharmacology | Lifetime | 904 | SE 27 | 95.74 |
| Orthopedics and Sports Medicine | Lifetime | 834 | SE 25 | 88.44 |
| Rehabilitation | Lifetime | 891 | SE 20 | 72.70 |
| Surgery | 2021-2025 | 134 | SE 2 | 99.22 |
| Rheumatology | 2021-2025 | 41 | SE 2 | 99.26 |
| Clinical Pharmacology | 2021-2025 | 196 | SE 2 | 93.07 |
| Orthopedics and Sports Medicine | 2021-2025 | 327 | SE 11 | 79.17 |
| Psychiatry and Mental health | 2021-2025 | 845 | SE 34 | 64.41 |
| Knee injuries and reconstruction techniques | Lifetime | 41 | SE 3 | 99.72 |
| Total Knee Arthroplasty Outcomes | Lifetime | 71 | SE 3 | 99.66 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 69 | SE 3 | 99.60 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 48 | SE 1 | 99.24 |
| Lower Extremity Biomechanics and Pathologies | Lifetime | 253 | SE 3 | 98.19 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 420 | SE 14 | 98.25 |
| Musculoskeletal pain and rehabilitation | Lifetime | 814 | SE 37 | 97.77 |
| Orthopedic Surgery and Rehabilitation | Lifetime | 733 | SE 17 | 97.76 |
| Shoulder Injury and Treatment | Lifetime | 769 | SE 15 | 97.70 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 412 | SE 15 | 96.45 |
| Hip disorders and treatments | Lifetime | 650 | SE 16 | 96.08 |
| Spondyloarthritis Studies and Treatments | Lifetime | 417 | SE 8 | 96.09 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 362 | SE 10 | 90.52 |
| Vasculitis and related conditions | Lifetime | 853 | SE 19 | 93.27 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 641 | SE 4 | 90.15 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 16 | SE 1 | 99.25 |
| Total Knee Arthroplasty Outcomes | 2021-2025 | 51 | SE 1 | 99.13 |
| Knee injuries and reconstruction techniques | 2021-2025 | 46 | SE 3 | 98.76 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 17 | SE 1 | 96.10 |
| Musculoskeletal pain and rehabilitation | 2021-2025 | 248 | SE 5 | 96.92 |
| Chronic Disease Management Strategies | 2021-2025 | 222 | SE 8 | 93.53 |
| Lower Extremity Biomechanics and Pathologies | 2021-2025 | 163 | SE 2 | 94.73 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 358 | SE 15 | 94.78 |
| Clinical practice guidelines implementation | 2021-2025 | 154 | SE 2 | 88.40 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 419 | SE 12 | 87.02 |
| Hip disorders and treatments | 2021-2025 | 474 | SE 7 | 85.75 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 356 | SE 6 | 73.97 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 237 | SE 3 | 71.67 |
| Musculoskeletal synovial abnormalities and treatments | 2021-2025 | 439 | SE 7 | 69.42 |
